Adam StrydomJan 181 minHealthcareSolid FY22 Marked by Broad-Based GrowthERGOMED, a services business which includes an industry-leading suite of specialist pharmacovigilance solutions, reported FY22 results...
Adam StrydomJan 181 minHealthcareCresemba Expansion Continues with Japan LaunchBasilea Pharmaceutica has announced that it has received a development-related milestone payment of CHF5m from its Japanese licensing...
Adam StrydomJan 181 minHealthcareStrong Execution Resulting in Operating ProfitabilityOn the heels of management’s January upward guidance revision, continued strong execution of Basilea Pharmaceutica’s outlined strategic...
Adam StrydomJan 181 minHealthcareCresemba Milestone Payment TriggeredBasilea Pharmaceutica has announced that it has received a sales-related milestone payment of CHF20m from its US licensing partner...
Adam StrydomJan 181 minHealthcareThird Leg of Strategy Executed With Debt RepaymentBasilea Pharmaceutica is focused on treating infectious diseases. Basilea has announced the full repayment of the CHF113.8m outstanding...